Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stefano Rusconi, Ospedale L. Sacco - Polo Universitario
ClinicalTrials.gov Identifier:
NCT00884858
First received: April 20, 2009
Last updated: April 29, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
No publications provided by Ospedale L. Sacco – Polo Universitario

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):